Skip to main content
    D

    Dogwood Therapeutics, Inc. (DWTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.08
    +0.02 (+1.89%)

    Market Cap: $40.52M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Dogwood Therapeutics, Inc. (DWTX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Dogwood Therapeutics (DWTX) has a market cap of $40.52M and an enterprise value of $35.57M. It kept -25179.61% of revenue as net income over the last 12 months. Its share count is up 1678.11% from a year earlier.

    Total Valuation

    Enterprise value is 12.21% below the market cap, as cash exceeds debt.

    Market Cap$40.52M
    Enterprise Value$35.57M
    Latest price (Nov 17, 2026)$1.08

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 454.42% a year over 2 years.

    Shares Outstanding34.13M
    Shares Change (YoY)+1678.11%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+454.42%

    Valuation Ratios

    Sales and book value multiples are 368.6x and 0.6x.

    P/S Ratio368.6x
    Forward P/S405.2x
    P/B Ratio0.6x

    Price Statistics

    The stock is down 80.61% over 52 weeks and trades 20.59% below its 50-day average.

    Beta (1Y)0.80
    52-Week Change-80.61%
    1-Month Change-10.74%
    3-Month Change-53.25%
    6-Month Change-41.62%
    5-Year Change-98.90%
    Total Return (1Y)-80.61%
    Total Return (3Y CAGR)-61.18%
    Total Return (5Y CAGR)-62.21%
    Return vs SPY (1Y)-94.00%
    Max Drawdown (1Y)-84.90%
    Max Drawdown (3Y)-95.10%
    Sharpe Ratio (1Y)-1.93
    Correlation with SPY (1Y)0.12
    50-Day Average$1.36
    200-Day Average$1.87
    52-Week Range$0.90 to $7.04
    RSI (14 Days)40.0
    Average Volume (20 Days)104.04K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.78x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.78x
    Quick Ratio2.78x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -39.26% and return on assets is -33.30% over the last 12 months.

    Return on Equity (ROE)-39.26%
    Return on Assets (ROA)-33.30%
    ROA (5Y Average)-85.15%
    ROIC (5Y Average)-37.38%
    Asset Turnover0.00x

    Scores

    DWTX has an Altman Z-Score of -1.62, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-1.62
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $100.00K over the last 12 months.

    Revenue$100.00K
    Operating Income-$27.86M
    Pretax Income-$27.63M
    Net Income-$25.18M
    Reported EPS (TTM)-$0.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 84.82% of the $75.61M in total assets.

    Cash and Equivalents$4.95M
    Total Debt$0
    Net Cash$4.95M
    Net Cash Per Share$0.14
    Working Capital$3.87M
    Shareholder Equity$64.13M
    Book Value Per Share$1.88
    Tangible Book Value-$5.28M
    Total Assets$75.61M
    Total Liabilities$11.47M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$16.47M
    FCF Per Share-$0.43

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -27863.47%.

    Operating Margin-27863.47%
    Pretax Margin-27628.11%
    Net Margin-25179.61%

    Dividends and Yields

    DWTX does not pay a dividend.

    Buyback Yield0.29%
    Shareholder Yield0.29%

    Stock Splits

    The last split was a 1-for-25 reverse split on Oct 9, 2024.

    Last Split DateOct 9, 2024
    Split TypeReverse split
    Split Ratio1:25

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DWTX

    What is DWTX's market cap?

    Dogwood Therapeutics has a market cap of $40.52M. Its enterprise value, which adds debt and subtracts cash, is $35.57M.

    How many shares of DWTX are outstanding?

    Dogwood Therapeutics has 34.13M shares outstanding. The count is up 1678.11% from a year earlier.

    Does DWTX pay a dividend?

    No. Dogwood Therapeutics does not pay a dividend.

    How much debt does DWTX have?

    Dogwood Therapeutics has $0 of total debt and $4.95M of cash and equivalents, a net cash position of $4.95M.